Annual Shareholders Equity
-$28.46 M
-$8.43 M-42.12%
December 31, 2023
Summary
- As of February 21, 2025, NERV annual stockholders equity is -$28.46 million, with the most recent change of -$8.43 million (-42.12%) on December 31, 2023.
- During the last 3 years, NERV annual shareholders equity has fallen by -$81.12 million (-154.04%).
- NERV annual shareholders equity is now -121.62% below its all-time high of $131.60 million, reached on December 31, 2017.
Performance
NERV Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
-$21.67 M
+$22.82 M+51.29%
September 30, 2024
Summary
- As of February 21, 2025, NERV quarterly stockholders equity is -$21.67 million, with the most recent change of +$22.82 million (+51.29%) on September 30, 2024.
- Over the past year, NERV quarterly shareholders equity has dropped by -$1.62 million (-8.10%).
- NERV quarterly shareholders equity is now -116.47% below its all-time high of $131.60 million, reached on December 31, 2017.
Performance
NERV Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
NERV Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -42.1% | -8.1% |
| 3 y3 years | -154.0% | -8.1% |
| 5 y5 years | -131.5% | -8.1% |
NERV Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -456.8% | at low | -371.7% | +51.3% |
| 5 y | 5-year | -154.0% | at low | -137.3% | +51.3% |
| alltime | all time | -121.6% | at low | -116.5% | +51.3% |
Minerva Neurosciences Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$21.67 M(-51.3%) |
| Jun 2024 | - | -$44.49 M(+21.6%) |
| Mar 2024 | - | -$36.59 M(+28.6%) |
| Dec 2023 | -$28.46 M(+42.1%) | -$28.46 M(+42.0%) |
| Sep 2023 | - | -$20.05 M(+60.2%) |
| Jun 2023 | - | -$12.51 M(-53.0%) |
| Mar 2023 | - | -$26.62 M(+32.9%) |
| Dec 2022 | -$20.02 M(-351.1%) | -$20.02 M(+40.6%) |
| Sep 2022 | - | -$14.25 M(+70.0%) |
| Jun 2022 | - | -$8.38 M(+1038.7%) |
| Mar 2022 | - | -$736.10 K(-109.2%) |
| Dec 2021 | $7.98 M(-84.9%) | $7.98 M(-71.6%) |
| Sep 2021 | - | $28.08 M(-22.4%) |
| Jun 2021 | - | $36.17 M(-20.3%) |
| Mar 2021 | - | $45.37 M(-13.8%) |
| Dec 2020 | $52.66 M(+89.6%) | $52.66 M(-9.2%) |
| Sep 2020 | - | $58.02 M(+1.9%) |
| Jun 2020 | - | $56.94 M(+205.8%) |
| Mar 2020 | - | $18.62 M(-33.0%) |
| Dec 2019 | $27.78 M | $27.78 M(-50.0%) |
| Sep 2019 | - | $55.53 M(-17.5%) |
| Jun 2019 | - | $67.27 M(-13.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $77.42 M(-14.2%) |
| Dec 2018 | $90.26 M(-31.4%) | $90.26 M(-11.0%) |
| Sep 2018 | - | $101.39 M(-8.4%) |
| Jun 2018 | - | $110.66 M(-8.8%) |
| Mar 2018 | - | $121.29 M(-7.8%) |
| Dec 2017 | $131.60 M(+24.2%) | $131.60 M(+1.1%) |
| Sep 2017 | - | $130.18 M(+32.8%) |
| Jun 2017 | - | $98.03 M(-7.8%) |
| Mar 2017 | - | $106.29 M(+0.3%) |
| Dec 2016 | $105.98 M(+91.6%) | $105.98 M(-6.3%) |
| Sep 2016 | - | $113.14 M(-6.2%) |
| Jun 2016 | - | $120.61 M(+81.0%) |
| Mar 2016 | - | $66.65 M(+20.5%) |
| Dec 2015 | $55.32 M(+7.4%) | $55.32 M(-12.3%) |
| Sep 2015 | - | $63.07 M(-7.8%) |
| Jun 2015 | - | $68.38 M(-8.1%) |
| Mar 2015 | - | $74.44 M(+44.5%) |
| Dec 2014 | $51.50 M(+155.2%) | $51.50 M(-9.2%) |
| Sep 2014 | - | $56.72 M(+94.0%) |
| Jun 2014 | - | $29.23 M(-14.2%) |
| Mar 2014 | - | $34.09 M(+68.9%) |
| Dec 2013 | $20.18 M(>+9900.0%) | $20.18 M |
| Dec 2012 | $19.00 K | - |
FAQ
- What is Minerva Neurosciences annual stockholders equity?
- What is the all time high annual shareholders equity for Minerva Neurosciences?
- What is Minerva Neurosciences annual shareholders equity year-on-year change?
- What is Minerva Neurosciences quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Minerva Neurosciences?
- What is Minerva Neurosciences quarterly shareholders equity year-on-year change?
What is Minerva Neurosciences annual stockholders equity?
The current annual shareholders equity of NERV is -$28.46 M
What is the all time high annual shareholders equity for Minerva Neurosciences?
Minerva Neurosciences all-time high annual stockholders equity is $131.60 M
What is Minerva Neurosciences annual shareholders equity year-on-year change?
Over the past year, NERV annual stockholders equity has changed by -$8.43 M (-42.12%)
What is Minerva Neurosciences quarterly stockholders equity?
The current quarterly shareholders equity of NERV is -$21.67 M
What is the all time high quarterly shareholders equity for Minerva Neurosciences?
Minerva Neurosciences all-time high quarterly stockholders equity is $131.60 M
What is Minerva Neurosciences quarterly shareholders equity year-on-year change?
Over the past year, NERV quarterly stockholders equity has changed by -$1.62 M (-8.10%)